Comment from International Consortium for Innovation and Quality in Pharmaceutical Development

Summary: The International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) supports the proposed pilot program and provides detailed recommendations on its design, metrics, and operational structure. They advocate for a multi-tiered approach to AI integration, emphasizing the need for clear validation, pre-competitive collaboration, and specific metrics to measure safety, efficiency, and model performance.